Global Liposomes Drug Delivery Market Growth 2020-2025
- ID:PD013953
- July 2020
- LPI (LP Information)
The global Liposomes Drug Delivery market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform. The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels. For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.
According to this study, over the next five years the Liposomes Drug Delivery market will register a 13.3%% CAGR in terms of revenue, the global market size will reach $ 5397.1 million by 2025, from $ 3277.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Liposomes Drug Delivery business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes Drug Delivery market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Liposomes Drug Delivery, covering the supply chain analysis, impact assessment to the Liposomes Drug Delivery market size growth rate in several scenarios, and the measures to be undertaken by Liposomes Drug Delivery companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- Gilead Sciences
- Novartis
- Pacira
- Johnson & Johnson
- Luye Pharma
- Sun Pharmaceutical
- CSPC
- Sigma-Tau Group
- Teva Pharmaceutical
- Ipsen (Onivyde)
- Fudan-Zhangjiang
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Liposomes Drug Delivery consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Liposomes Drug Delivery market by identifying its various subsegments.
- Focuses on the key global Liposomes Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Liposomes Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Liposomes Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposomes Drug Delivery Consumption 2015-2025
2.1.2 Liposomes Drug Delivery Consumption CAGR by Region
2.2 Liposomes Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposomes Drug Delivery Consumption by Type
2.3.1 Global Liposomes Drug Delivery Consumption Market Share by Type (2015-2020)
2.3.2 Global Liposomes Drug Delivery Revenue and Market Share by Type (2015-2020)
2.3.3 Global Liposomes Drug Delivery Sale Price by Type (2015-2020)
2.4 Liposomes Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposomes Drug Delivery Consumption by Application
2.5.1 Global Liposomes Drug Delivery Consumption Market Share by Type (2015-2020)
2.5.2 Global Liposomes Drug Delivery Value and Market Share by Type (2015-2020)
2.5.3 Global Liposomes Drug Delivery Sale Price by Type (2015-2020)
3 Global Liposomes Drug Delivery by Company
3.1 Global Liposomes Drug Delivery Sales Market Share by Company
3.1.1 Global Liposomes Drug Delivery Sales by Company (2018-2020)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Company (2018-2020)
3.2 Global Liposomes Drug Delivery Revenue Market Share by Company
3.2.1 Global Liposomes Drug Delivery Revenue by Company (2018-2020)
3.2.2 Global Liposomes Drug Delivery Revenue Market Share by Company (2018-2020)
3.3 Global Liposomes Drug Delivery Sale Price by Company
3.4 Global Liposomes Drug Delivery Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Liposomes Drug Delivery Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Liposomes Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Liposomes Drug Delivery by Regions
4.1 Liposomes Drug Delivery by Regions
4.2 Americas Liposomes Drug Delivery Consumption Growth
4.3 APAC Liposomes Drug Delivery Consumption Growth
4.4 Europe Liposomes Drug Delivery Consumption Growth
4.5 Middle East & Africa Liposomes Drug Delivery Consumption Growth
5 Americas
5.1 Americas Liposomes Drug Delivery Consumption by Countries
5.1.1 Americas Liposomes Drug Delivery Consumption by Countries (2015-2020)
5.1.2 Americas Liposomes Drug Delivery Value by Countries (2015-2020)
5.2 Americas Liposomes Drug Delivery Consumption by Type
5.3 Americas Liposomes Drug Delivery Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Liposomes Drug Delivery Consumption by Regions
6.1.1 APAC Liposomes Drug Delivery Consumption by Regions (2015-2020)
6.1.2 APAC Liposomes Drug Delivery Value by Regions (2015-2020)
6.2 APAC Liposomes Drug Delivery Consumption by Type
6.3 APAC Liposomes Drug Delivery Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Liposomes Drug Delivery by Countries
7.1.1 Europe Liposomes Drug Delivery Consumption by Countries (2015-2020)
7.1.2 Europe Liposomes Drug Delivery Value by Countries (2015-2020)
7.2 Europe Liposomes Drug Delivery Consumption by Type
7.3 Europe Liposomes Drug Delivery Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Liposomes Drug Delivery by Countries
8.1.1 Middle East & Africa Liposomes Drug Delivery Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Liposomes Drug Delivery Value by Countries (2015-2020)
8.2 Middle East & Africa Liposomes Drug Delivery Consumption by Type
8.3 Middle East & Africa Liposomes Drug Delivery Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Liposomes Drug Delivery Distributors
10.3 Liposomes Drug Delivery Customer
11 Global Liposomes Drug Delivery Market Forecast
11.1 Global Liposomes Drug Delivery Consumption Forecast (2021-2025)
11.2 Global Liposomes Drug Delivery Forecast by Regions
11.2.1 Global Liposomes Drug Delivery Forecast by Regions (2021-2025)
11.2.2 Global Liposomes Drug Delivery Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Liposomes Drug Delivery Forecast by Type
11.8 Global Liposomes Drug Delivery Forecast by Application
12 Key Players Analysis
12.1 Gilead Sciences
12.1.1 Company Information
12.1.2 Liposomes Drug Delivery Product Offered
12.1.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Gilead Sciences Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Liposomes Drug Delivery Product Offered
12.2.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Pacira
12.3.1 Company Information
12.3.2 Liposomes Drug Delivery Product Offered
12.3.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pacira Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Liposomes Drug Delivery Product Offered
12.4.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Luye Pharma
12.5.1 Company Information
12.5.2 Liposomes Drug Delivery Product Offered
12.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Luye Pharma Latest Developments
12.6 Sun Pharmaceutical
12.6.1 Company Information
12.6.2 Liposomes Drug Delivery Product Offered
12.6.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sun Pharmaceutical Latest Developments
12.7 CSPC
12.7.1 Company Information
12.7.2 Liposomes Drug Delivery Product Offered
12.7.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CSPC Latest Developments
12.8 Sigma-Tau Group
12.8.1 Company Information
12.8.2 Liposomes Drug Delivery Product Offered
12.8.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sigma-Tau Group Latest Developments
12.9 Teva Pharmaceutical
12.9.1 Company Information
12.9.2 Liposomes Drug Delivery Product Offered
12.9.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Teva Pharmaceutical Latest Developments
12.10 Ipsen (Onivyde)
12.10.1 Company Information
12.10.2 Liposomes Drug Delivery Product Offered
12.10.3 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Ipsen (Onivyde) Latest Developments
12.11 Fudan-Zhangjiang
12.11.1 Company Information
12.11.2 Liposomes Drug Delivery Product Offered
12.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Fudan-Zhangjiang Latest Developments
13 Research Findings and Conclusion
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
Global Radiopharmaceuticals Market Insights, Forecast to 2025
Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under read more..
Global Neurorehabilitation System Market Research Report
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
Global Molecular Biology Kits And Reagents Market Research Report
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
Global High Acuity Care Information Systems Market Research Report
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
Global Regenerative Medicine Market Research Report
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
Global Skin Cancer Diagnostics Market Research Report
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..